Steep Hill Valuation Multiples

Discover Steep Hill's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like SOL Global Investments, Agrios Global Holdings, Grow Solutions Holdings, The Cannabist Company and more.

Steep Hill Overview

About Steep Hill

Steep Hill Inc is a science and technology health and wellness company focused on the hemp markets inclusive of plant-based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. Currently the company, through its subsidiaries holds three industrial hemp licences for the purposes of supplying the market with medicinal and wellness cannabidiol and other cannabinoid-based products.


Founded

2018

HQ

Canada

Employees

7

Financials (FY)

Revenue: -
Net Income: -

Market Cap

$646K

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Steep Hill Stock Performance

Steep Hill has current market cap of $646K.


Steep Hill's stock price is $0.24.

See more trading valuation data for Steep Hill
Market CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$646K0.0%----

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Steep Hill Valuation Multiples

Steep Hill Financial Valuation Multiples

As of August 14, 2026, Steep Hill has market cap of $646K.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Steep Hill Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Steep Hill Competitors

Steep Hill competitors include SOL Global Investments, Agrios Global Holdings, Grow Solutions Holdings, The Cannabist Company, RAMM Pharma, Ayr Wellness, Pharmadrug, Indoor Harvest, Xebra Brands and Aion Therapeutic.

Most Steep Hill public comparables operate across Cannabis, CannaTech and ViceTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
SOL Global Investments(0.1x)---
Agrios Global Holdings----
Grow Solutions Holdings----
The Cannabist Company0.9x-14.9x-
RAMM Pharma0.3x-(0.1x)-
Ayr Wellness1.3x-(3.9x)-
Pharmadrug--(35.7x)-
Indoor Harvest--(0.4x)-

This data is available for Pro users. Sign up to see all Steep Hill competitors and their valuation data.

Start Free Trial

Steep Hill VC Funding History

Before going public, Steep Hill raised $20M in total equity funding, across 8 rounds.


Steep Hill Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Aug-18SeedMerida Capital Holdings$4M-Steep Hill, Inc. is a cannabis science and technology company founded in 2008 and based in Berkeley, California, specializing in laboratory testing, analytics, and related services for regulated cannabis and hemp markets. The company offers potency testing, safety screening, genetic analysis, cultivation science, and scientific consulting, with operations including corporate-owned laboratories in California, New Mexico, and Washington State, along with licensees across the U.S. and internationally in countries including Canada, France, Germany, Italy, Mexico, Spain, Switzerland, and the United Kingdom. In August 2018, Merida Capital Partners, one of Steep Hill's lead investors, increased its stake in the company as part of a broader investment round. Merida's partner Jeffrey Monat joined Steep Hill's Board of Directors alongside newly appointed board members Brett Finkelstein and Stephen Finfer. In connection with this investment, Dr. Andrew Rosenstein was selected to assume the role of interim CEO, replacing Jmîchaeĺe Keller. The company operated as a leader in cannabis science with a foundation built on compliance testing and had been on the cutting edge of the industry since opening the first commercial cannabis lab in the United States in 2008.
Sep-17Seed-$3M--
Aug-17Seed-$2M--
May-17Seed-$2M--
Dec-16SeedMerida Capital Holdings$1M--
Jan-16Seed-$2M--
Aug-15Seed-$2M--
Mar-14Seed-$4M--

Acquisitions by Steep Hill

Steep Hill has acquired 2 companies to date.

Last acquisition by Steep Hill was on August 6th 2026. Steep Hill acquired Alchemy Analytics for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Steep Hill

Alchemy Analytics
LIR life Sciences
Description
Alchemy Analytics is a testing laboratory focused on quality verification for medical cannabis products.
LIR Life Sciences is a biopharmaceutical company developing treatments for obesity and metabolic disorders while expanding into additional therapy areas with next-generation drug candidates.
HQ Country-Canada
HQ City
-
Vancouver
Deal Date6 Aug 202612 Feb 2025
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Steep Hill acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Steep Hill

When was Steep Hill founded?Steep Hill was founded in 2018.
Where is Steep Hill headquartered?Steep Hill is headquartered in Canada.
How many employees does Steep Hill have?As of today, Steep Hill has over 7 employees.
Is Steep Hill publicly listed?Yes, Steep Hill is a public company listed on Canadian Securities Exchange.
What is the stock symbol of Steep Hill?Steep Hill trades under STPH ticker.
When did Steep Hill go public?Steep Hill went public in 2020.
Who are competitors of Steep Hill?Steep Hill main competitors include SOL Global Investments, Agrios Global Holdings, Grow Solutions Holdings, The Cannabist Company, RAMM Pharma, Ayr Wellness, Pharmadrug, Indoor Harvest, Xebra Brands, Aion Therapeutic.
What is the current market cap of Steep Hill?Steep Hill's current market cap is $646K.
Is Steep Hill profitable?No, Steep Hill is not profitable.
How many companies Steep Hill has acquired to date?As of August 2026, Steep Hill has acquired 2 companies.
What was the largest acquisition by Steep Hill?None of the M&A deals Steep Hill has completed have disclosed valuations.
What companies Steep Hill acquired?Steep Hill acquired LIR life Sciences and Alchemy Analytics.
In how many companies Steep Hill has invested to date?Steep Hill hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Steep Hill

Lists including Steep Hill

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial